S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

NLSP NLS Pharmaceutics Ltd

0.207

0.002 (0.98%)

Last Updated: 13:59:55

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

NLS Pharmaceutics (NASDAQ:NLSP)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more NLS Pharmaceutics Charts.

NLS Pharmaceutics (NASDAQ:NLSP)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more NLS Pharmaceutics Charts.

NLS Pharmaceutics Ltd News

Form D - Notice of Exempt Offering of Securities
Monday 15 July 2024 (1 day ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 11 March 2024 (4 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 23 February 2024 (5 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 12 January 2024 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 29 December 2023 (7 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 22 December 2023 (7 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 6 December 2023 (7 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 December 2023 (7 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 December 2023 (7 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 1 December 2023 (8 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 16 November 2023 (8 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 25 October 2023 (9 months ago) • Edgar (US Regulatory)

More NLS Pharmaceutics Ltd News Articles

Ubiquitech Software (PK)

Faraday Future Intellige...

Rennova Health (PK)

Intergrated Cannabis Sol... (PK)

Fannie Mae (QB)

Enzolytics (PK)

NioCorp Developments

Decentral Life (PK)

Ronn Motor (PK)

Digital Brand Media and ... (PK)

Brookmount Explorations (PK)

1812 Brewing (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions